SKI Market

A+| A| A-|

Indian Indices

Sensex

76,809.06 -661.05
( -0.85%)

Global Indices

Nasdaq

52,245.67 385.41
(0.74%)

Dow Jones

7,529.66 65.38
(0.88%)

Hang Seng

66,064.76 1,923.64
(3.00%)

Nikkei 225

10,580.59 55.83
(0.53%)

Forex

USD-INR

96.43 0.01
(0.01%)

EUR-INR

110.17 -0.09
(-0.08%)

GBP-INR

129.67 0.03
(0.02%)

JPY-INR

0.59 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Avience Biomedicals Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

94324

INE0V9I01017

157.0914426

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AVIENCE

20.48

137.95

EPS(TTM)

Face Value()

Div & Yield %

12.28

Back

modern engineering & projects limited

Stellant Securities (India) reports standalone net loss of Rs 4.64 crore in the December 2025 quarter

Feb 27,2026

Net loss of Stellant Securities (India) reported to Rs 4.64 crore in the quarter ended December 2025 as against net profit of Rs 0.10 crore during the previous quarter ended December 2024. Sales rose 726.67% to Rs 1.24 crore in the quarter ended December 2025 as against Rs 0.15 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1.24	0.15	727
OPM %	-502.42	93.33	-
PBDT	-6.20	0.14	PL
PBT	-6.20	0.14	PL
NP	-4.64	0.10	PL

76,809.06 -661.05 ( -0.85%)

52,245.67 385.41 (0.74%)

7,529.66 65.38 (0.88%)

66,064.76 1,923.64 (3.00%)

10,580.59 55.83 (0.53%)

96.43 0.01 (0.01%)

110.17 -0.09 (-0.08%)

129.67 0.03 (0.02%)

0.59 0.00 (0.01%)